Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases
BLEND
1 other identifier
interventional
13
1 country
1
Brief Summary
The aim of this study is to assess the feasibility and safety of combining stereotactic body radiotherapy (SBRT) and pedicle screw fixation in a 48-hour window for the treatment of painful unstable metastases of the thoracic and/or lumbar spine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Jun 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 17, 2015
CompletedFirst Posted
Study publicly available on registry
December 7, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedMay 8, 2017
May 1, 2017
1.8 years
September 17, 2015
May 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of adverse events
Occurrence of adverse events grade 3/4 according to the common terminology criteria for adverse events (CTCAE) 4.0
first 90 days post treatment
Secondary Outcomes (8)
Pain response
first 90 days post treatment
Duration of pain relief
first 90 days post treatment
Rapidity of pain relief
first 90 days post treatment
Hospital stay
first 90 days post treatment
Early mortality
First 30 days post treatment
- +3 more secondary outcomes
Study Arms (1)
BLEND
EXPERIMENTALCombination of stereotactic bodyradiotherapy and surgical stabilization within 48 hours for the treatment of unstable spinal metastases.
Interventions
Eligibility Criteria
You may qualify if:
- Painful metastases from solid tumors in the thoracic or lumbar spine needing surgical stabilization
- Histologic proof of malignancy
- Radiographic evidence of spinal metastases
- Karnofsky performance status ≤ 50
- Written informed consent
You may not qualify if:
- Multiple spinal metastases necessitating bridging more than five vertebral levels during surgery
- Previous surgery or radiotherapy to index lesion
- stereotactic body radiotherapy cannot be delivered (Bilsky score 2 and 3)
- Neurological deficits (ASIA C, B or A)
- Partial neurological deficits (ASIA D) with rapid progression (hours to days)
- Inability to lie flat on table for stereotactic body radiotherapy
- Non-ambulatory patients
- Patient in hospice or with \< 3 months life expectancy
- Medically inoperable or patient refused surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UMC Utrechtlead
Study Sites (1)
University Medical Center Utrecht
Utrecht, 3584 CX, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jorrit-Jan Verlaan, MD, PhD
UMC Utrecht
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
September 17, 2015
First Posted
December 7, 2015
Study Start
June 1, 2015
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
May 8, 2017
Record last verified: 2017-05